ALCAlcon Inc.
49.61CHF-1.10%Mkt Cap: 24.19B CHFP/E: 38.16Last update: 2026-05-13

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics…

loading…
Indicators:|

Key Statistics

Valuation
P/E (Trailing)38.16
P/E (Forward)14.69
PEG1.42
P/B1.43
P/S2.31
EV/EBITDA12.45
EV/Revenue2.65
EPS (TTM)1.31
EPS (Forward)3.43
Cash Flow & Leverage
FCF Yield4.93%
FCF Margin11.21%
Operating CF2.27B CHF
CapEx (TTM)663.00M CHF
Net Debt/EBITDA1.59
Net Debt3.60B CHF
Technical
SMA 5058.75 (-15.6%)
SMA 20061.81 (-19.7%)
Beta0.70
S&P 52W Chg24.23%
Avg Vol (30d)1.39M
Avg Vol (10d)2.87M
Technical Indicators
RSI (14)24.4
MACD-3.0609
MACD Signal-2.0355
MACD Hist.-1.0254
BB Upper67.75 CHF
BB Middle57.28 CHF
BB Lower46.81 CHF
BB Width36.56%
ATR (14)1.678 CHF
Vol Ratio (20d)1.21x
52W Range
47.805% of range80.96
52W High80.96 CHF
52W Low47.80 CHF
Profitability
Gross Margin55.24%
EBITDA Margin21.30%
Profit Margin9.42%
Oper. Margin10.79%
ROE4.45%
ROA3.11%
Revenue Growth9.40%
Earnings Growth-44.60%
Balance Sheet
Debt/Equity0.02
Current Ratio2.20
Quick Ratio1.22
Book Value/Sh35.32 CHF
Cash/Share3.402 CHF
Dividends
Fwd Div Rate0.2800 CHF
Trail. Div Rate0.3530 CHF
Div. Yield0.56%
5Y Avg Yield0.30%
Payout Ratio20.39%
Ex-Div DateMay 5, 2026
Pay DateMay 15, 2025
Ownership
Shares Out.487.70M
Float486.37M
Insiders0.17%
Institutions67.23%
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)75.86 CHF
Target Range50.44 CHF88.81 CHF
# Analysts17
Company
Market Cap24.19B CHF
Enterprise Value28.19B CHF
Revenue (TTM)10.63B CHF
Gross Profit5.75B CHF
Net Income (TTM)980.00M CHF
Revenue/Share21.65 CHF
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees25.0K
Last Price49.61 CHF
CountryCH
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINCH0432492467